IS4615A - Mótefnavakar Helicobacter pylori og bóluefnablöndur - Google Patents

Mótefnavakar Helicobacter pylori og bóluefnablöndur

Info

Publication number
IS4615A
IS4615A IS4615A IS4615A IS4615A IS 4615 A IS4615 A IS 4615A IS 4615 A IS4615 A IS 4615A IS 4615 A IS4615 A IS 4615A IS 4615 A IS4615 A IS 4615A
Authority
IS
Iceland
Prior art keywords
helicobacter pylori
vaccine preparations
antigen
antigen helicobacter
vaccine
Prior art date
Application number
IS4615A
Other languages
English (en)
Inventor
Bölin Ingrid
Svennerholm Ann-Mari
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9502007A external-priority patent/SE9502007D0/xx
Priority claimed from SE9601085A external-priority patent/SE9601085D0/xx
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of IS4615A publication Critical patent/IS4615A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IS4615A 1995-06-01 1997-11-17 Mótefnavakar Helicobacter pylori og bóluefnablöndur IS4615A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9502007A SE9502007D0 (sv) 1995-06-01 1995-06-01 Novel polypeptides
SE9601085A SE9601085D0 (sv) 1996-03-21 1996-03-21 Novel polypeptides
PCT/SE1996/000727 WO1996038475A1 (en) 1995-06-01 1996-06-03 Helicobacter pylori antigens and vaccine compositions

Publications (1)

Publication Number Publication Date
IS4615A true IS4615A (is) 1997-11-17

Family

ID=26662316

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4615A IS4615A (is) 1995-06-01 1997-11-17 Mótefnavakar Helicobacter pylori og bóluefnablöndur

Country Status (22)

Country Link
US (2) US6025164A (is)
EP (1) EP0828757A1 (is)
JP (1) JP3380559B2 (is)
KR (1) KR19990022131A (is)
CN (1) CN1191544A (is)
AR (1) AR003125A1 (is)
BR (1) BR9608627A (is)
CA (1) CA2222797A1 (is)
CZ (1) CZ357397A3 (is)
EE (1) EE9700306A (is)
HU (1) HUP9901546A3 (is)
IL (1) IL122340A0 (is)
IS (1) IS4615A (is)
MY (1) MY119003A (is)
NO (1) NO975490L (is)
NZ (1) NZ303356A (is)
PL (1) PL323741A1 (is)
RU (1) RU2195463C2 (is)
SK (1) SK155297A3 (is)
TR (1) TR199701471T1 (is)
TW (1) TW570925B (is)
WO (1) WO1996038475A1 (is)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2682122B1 (fr) * 1991-10-03 1995-06-09 Pasteur Institut Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori.
US5843460A (en) * 1993-05-19 1998-12-01 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
WO1995014093A1 (en) 1993-05-19 1995-05-26 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides
US5871749A (en) * 1993-07-27 1999-02-16 Csl Limited Therapeutic treatment of H. pylori associated gastroduodenal disease
US6406703B1 (en) 1993-07-27 2002-06-18 Csl Limited Treatment of H. pylori associated gastroduodenal disease
AUPM612494A0 (en) * 1994-06-08 1994-06-30 Csl Limited Treatment or prevention of helicobacter infection
CN1186516A (zh) * 1995-06-07 1998-07-01 阿斯特拉公司 与幽门螺杆菌相关的诊断和治疗用的核酸和氨基酸序列
JP2001520671A (ja) * 1997-03-26 2001-10-30 アバント インミューノセラピューティクス，インコーポレイテッド ヘリコバクターピロリに対しポリクローナル抗血清と免疫反応する炭水化物抗原
CA2289253A1 (en) * 1997-04-30 1998-11-05 Merieux Oravax Anti-helicobacter vaccine composition for use by the subdiaphragmatic systemic route, and combined mucosal/parenteral immunization method
SE9702241D0 (sv) * 1997-06-12 1997-06-12 Astra Ab Vaccine compositions IV
SE9702242D0 (sv) * 1997-06-12 1997-06-12 Astra Ab Vaccine compositions V
US7393529B2 (en) 1998-04-09 2008-07-01 Idexx Laboratories, Inc. Methods and compositions for inhibiting binding of IgE to a high affinity receptor
SE9801288D0 (sv) * 1998-04-14 1998-04-14 Astra Ab Vaccine delivery system and metod of production
DE69922364T2 (de) * 1998-04-30 2005-11-03 Chiron S.R.L. Verfahren zur Immunisierung gegen und zur Behandlung von Infektionen durch H.pylori
AU3205000A (en) * 1999-02-19 2000-09-04 Astrazeneca Ab Expression of helicobacter polypeptides in pichia pastoris
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
AU2001258373A1 (en) * 2000-04-27 2001-11-12 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Method for identifying helicobacter antigens
GB0010371D0 (en) * 2000-04-29 2000-06-14 Astrazeneca Ab Helicobacter pylori antigens
US20020107368A1 (en) * 2000-12-07 2002-08-08 Jing-Hui Tian Helicobacter proteins, gene sequences and uses thereof
AU2004266213A1 (en) 2003-08-15 2005-03-03 University Of Florida Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
US7381547B2 (en) * 2004-04-28 2008-06-03 Tzam Diagnostics, Llc Methods and compositions to detect bacteria using multiplex PCR
KR100613924B1 (ko) * 2004-06-23 2006-08-21 현대자동차주식회사 자동차 연료 시스템
WO2007014179A2 (en) * 2005-07-25 2007-02-01 University Of Rochester Method for controlling immunodominance
JP2010524508A (ja) * 2007-04-27 2010-07-22 ダウ グローバル テクノロジーズ インコーポレイティド 可溶性組換え二十面体ウイルス様粒子の生産及びインビボ組織化の改善
CN101496898B (zh) * 2009-02-16 2011-06-15 中国人民解放军军事医学科学院生物工程研究所 一种预防和/或治疗幽门螺杆菌感染的疫苗
RU2449805C1 (ru) 2011-01-27 2012-05-10 Общество С Ограниченной Ответственностью "Гармония" Пептидная фармацевтическая композиция, средство на ее основе для лечения гастродуоденальных заболеваний, вызываемых helicobacter pylori, и способ его использования
CN108495650A (zh) 2015-12-14 2018-09-04 慕尼黑工业大学 幽门螺杆菌疫苗
US10577409B2 (en) * 2016-05-26 2020-03-03 Sagabio Co., Ltd. Monoclonal antibody inhibiting immunosuppressive functions of pathogens, antigen-binding fragment thereof, and hybridomas producing such antibody
CN107456578A (zh) * 2016-06-03 2017-12-12 硕英生医股份有限公司 一种关闭病原体的免疫抑制功能的方法及其用途
EP3272354A1 (en) 2016-07-20 2018-01-24 Technische Universität München Agents and methods for the prevention or treatment of h. pylori infections
CN111467368B (zh) * 2020-04-13 2021-05-28 江南大学 含庚糖链的寡糖化合物在制备幽门螺旋杆菌疫苗中的应用
CN113144182B (zh) * 2021-04-22 2023-03-10 成都欧林生物科技股份有限公司 一种幽门螺杆菌口服缓释疫苗及其制备与应用
CN113896775A (zh) * 2021-08-25 2022-01-07 河北医科大学第四医院 幽门螺杆菌特异性免疫原性肽段

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5601831A (en) * 1989-03-09 1997-02-11 Praxis Biologics, Inc. Vaccines for nontypable Haemophilus influenzae
RU2009507C1 (ru) * 1991-06-28 1994-03-15 Российский государственный медицинский университет Способ диагностики пилорического геликобактериоза
US5721349A (en) * 1992-02-26 1998-02-24 Vanderbilt University Vacuolating toxin-deficient H. pylori
MX9301706A (es) * 1992-04-13 1994-05-31 Oravax Inc Composicion de vacuna para el tratamiento de la infeccion por helicobacter.
US5420014A (en) * 1992-04-30 1995-05-30 Auspharm International Ltd. Rapid in vitro test for helicobacter pylori using saliva

Also Published As

Publication number Publication date
EP0828757A1 (en) 1998-03-18
SK155297A3 (en) 1998-08-05
NZ303356A (en) 1999-05-28
CA2222797A1 (en) 1996-12-05
TW570925B (en) 2004-01-11
WO1996038475A1 (en) 1996-12-05
BR9608627A (pt) 1999-06-15
HUP9901546A2 (hu) 1999-08-30
MY119003A (en) 2005-03-31
JPH11507210A (ja) 1999-06-29
AU703331B2 (en) 1999-03-25
MX9709194A (es) 1998-07-31
CZ357397A3 (cs) 1998-05-13
TR199701471T1 (xx) 1998-02-21
AR003125A1 (es) 1998-07-08
CN1191544A (zh) 1998-08-26
US20020168726A1 (en) 2002-11-14
PL323741A1 (en) 1998-04-14
HUP9901546A3 (en) 2003-07-28
IL122340A0 (en) 1998-04-05
EE9700306A (xx) 1998-06-15
KR19990022131A (ko) 1999-03-25
AU6020596A (en) 1996-12-18
NO975490L (no) 1998-01-07
JP3380559B2 (ja) 2003-02-24
US6025164A (en) 2000-02-15
NO975490D0 (no) 1997-11-28
RU2195463C2 (ru) 2002-12-27

Similar Documents

Publication Publication Date Title
IS4615A (is) Mótefnavakar Helicobacter pylori og bóluefnablöndur
NO944475L (no) Kombinerte vaksiner omfattende Hepatit B overflateantigen og andre antigener
AU3630093A (en) Helicobacter pylori proteins useful for vaccines and diagnostics
FI943171L (fi) Ureaasipohjainen rokote Helicobacter-infektiota vastaan
NO20071415L (no) OB-fusjonsproteinpreparater og fremgangsmater
DK0822831T3 (da) Vacciner indeholdende en saponin og en sterol
FI963281A7 (fi) Ureaasipohjainen rokote ja helicobakteeri-infektion hoito
NO985339D0 (no) Humane B-celleantigener og beslektede reagenser
DK0729956T3 (da) Benzothi9phenforbindelser, emllemprodukter, præparater og fremgangsmåder
NO943511L (no) Farmasöytiske preparater og anvendelse derav
NO982329D0 (no) Kreftvaksine og fremgangsmÕte for fremstilling derav
RU98100200A (ru) Антигены helicobacter pylori и вакцинные композиции
DK0765333T3 (da) Quillajasaponinadjuvans og vaccineformulering, der indeholder denne
IS5005A (is) Kjarnsýrur og amínósýruraðir er tengjast Helicobacter pylori og bóluefni úr þeim
NO965023D0 (no) Maltitolblanding og fremstilling derav
IS5047A (is) Kjarnsýru- og amínósýruraðir er tengjast Helicobacter pylori og bóluefni úr þeim
DK0863991T3 (da) Antigeniske præparater
DK32989D0 (da) Immunoglobulin-konjugater og fremgangsmaade til fremstilling deraf
FI973335L (fi) Helicobacter pylori-antigeeni
DK108990D0 (da) Svinedysenteri subenhedsvaccine og fremgangsmaade til fremstilling deraf
EP0770092A4 (en) PROTEIN D'-i (HELICOBARTER PYLORI) LINKED TO NICKEL
FI953257L (fi) Rekombinanttinen ihmisen prostaspesifinen antigeeni ja sen käytöt
NO974932L (no) Pesticidpreparater og fremgangsmåte for fremstilling derav
NO981407D0 (no) Protein fra Helicobacter pylori
IL116541A0 (en) Helicobacter proteins and vaccines